1. Home
  2. EVO vs INFN Comparison

EVO vs INFN Comparison

Compare EVO & INFN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EVO
  • INFN
  • Stock Information
  • Founded
  • EVO 1993
  • INFN 2000
  • Country
  • EVO Germany
  • INFN United States
  • Employees
  • EVO N/A
  • INFN N/A
  • Industry
  • EVO Biotechnology: Pharmaceutical Preparations
  • INFN Telecommunications Equipment
  • Sector
  • EVO Health Care
  • INFN Utilities
  • Exchange
  • EVO Nasdaq
  • INFN Nasdaq
  • Market Cap
  • EVO 1.6B
  • INFN 1.5B
  • IPO Year
  • EVO 2021
  • INFN 2007
  • Fundamental
  • Price
  • EVO $4.44
  • INFN $6.65
  • Analyst Decision
  • EVO Buy
  • INFN Buy
  • Analyst Count
  • EVO 2
  • INFN 9
  • Target Price
  • EVO $5.90
  • INFN $6.76
  • AVG Volume (30 Days)
  • EVO 46.1K
  • INFN 972.4K
  • Earning Date
  • EVO 11-06-2024
  • INFN 03-05-2025
  • Dividend Yield
  • EVO N/A
  • INFN N/A
  • EPS Growth
  • EVO N/A
  • INFN N/A
  • EPS
  • EVO N/A
  • INFN N/A
  • Revenue
  • EVO $866,665,179.00
  • INFN $1,457,515,000.00
  • Revenue This Year
  • EVO $3.84
  • INFN N/A
  • Revenue Next Year
  • EVO $10.94
  • INFN $10.36
  • P/E Ratio
  • EVO N/A
  • INFN N/A
  • Revenue Growth
  • EVO N/A
  • INFN N/A
  • 52 Week Low
  • EVO $2.85
  • INFN $4.41
  • 52 Week High
  • EVO $7.98
  • INFN $6.92
  • Technical
  • Relative Strength Index (RSI)
  • EVO 49.82
  • INFN 54.88
  • Support Level
  • EVO $4.40
  • INFN $6.60
  • Resistance Level
  • EVO $4.49
  • INFN $6.70
  • Average True Range (ATR)
  • EVO 0.10
  • INFN 0.04
  • MACD
  • EVO -0.00
  • INFN 0.00
  • Stochastic Oscillator
  • EVO 38.46
  • INFN 50.00

About EVO Evotec SE

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

About INFN Infinera Corporation

Infinera Corp is a global supplier of networking solutions comprised of networking equipment, software and services. Its portfolio of solutions includes optical transport platforms, converged packet-optical transport platforms, compact modular platforms, optical line systems, coherent optical subsystems, a suite of automation software offerings, and support and professional services. The company's customers include operators of fixed line and mobile networks, including telecommunications service providers, internet content providers, cable providers, wholesale carriers, research and education institutions, large enterprises, utilities and government entities.

Share on Social Networks: